To ensure consistent availability, the government must streamline API imports and maintain mandatory buffer stocks of essential cancer drugs. Simultaneously, local pharmaceutical companies should invest in domestic API manufacturing to lower costs and position Bangladesh as a regional treatment hub. Finally, a real-time digital dashboard connecting hospitals and regulators is essential to predict and prevent shortages before they occur.